SHZ · 300039.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:10 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shanghai Kaibao Pharmaceutical CO.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 28.8% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shanghai Kaibao Pharmaceutical CO.,Ltd’s forward annual dividend is CN¥0.20 per share, paid semi-annual. The forward yield is 4.16% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shanghai Kaibao Pharmaceutical CO.,Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research, development, manufacturing, and sale of modern Traditional Chinese Medicines, primarily operating within China. Its diverse product lineup features several key pharmaceutical solutions. These include: Tanreqing injection, which is extensively utilized for addressing conditions like pneumonia, acute and chronic bronchitis, and upper respiratory tract infections. Tanreqing capsules, formulated to reduce internal heat, detoxify the system, and clear phlegm. Tiopronin for injection, designed to enhance liver function for various acute and chronic hepatitis patients. Tiopronin enteric-coated tablets, prescribed as a supplementary therapy for managing chronic hepatitis. Xiongdan dropping pills, known for their efficacy in alleviating heat, calming the liver, and promoting improved vision. Established in 2000, the company's operations are based in Shanghai, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥56.52+CN¥2.30 (+4.24%)
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.74% below the high.
CN¥47.02-CN¥0.96 (-2.0%)
Hunan Warrant Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 27.22% below the high.
CN¥7.02+CN¥0.24 (+3.54%)
Jinghua Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.49% below the high.
CN¥26.88+CN¥0.66 (+2.52%)
Jiangsu Jibeier Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.06% below the high.
CN¥19.85+CN¥0.05 (+0.25%)
Shenzhen Weiguang Biological Products Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.02% below the high.
CN¥26.58+CN¥0.32 (+1.22%)
Jianmin Pharmaceutical Group Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.85% below the high.
CN¥12.72+CN¥0.17 (+1.35%)
Tianjin Lisheng Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.49% below the high.
CN¥1.27-CN¥0.00 (0.0%)
Shenzhen Neptunus Bioengineering Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 77.72% below the high.
